ABT (Abbott Laboratories) 3-Month Share Buyback Ratio : -0.47% (As of Mar. 2025 )

View and export this data going back to 1949. Start your Free Trial

What is Abbott Laboratories 3-Month Share Buyback Ratio?

Shares Outstanding (EOP) are shares that have been authorized, issued, and purchased by investors and are held by them.

3-Month Share Buyback Ratio measures the proportion of a company's outstanding shares repurchased over the past three months, calculated as the percentage change in shares outstanding from the previous quarter to the current quarter. A positive ratio may indicates share buybacks over the period, while a zero or negative ratio suggests no buybacks or potential share issuance. Abbott Laboratories's current 3-Month Share Buyback Ratio was -0.47%.

Competitive Comparison of Abbott Laboratories's 3-Month Share Buyback Ratio

For the Medical Devices subindustry, Abbott Laboratories's 3-Month Share Buyback Ratio, along with its competitors' market caps and 3-Month Share Buyback Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Abbott Laboratories's 3-Month Share Buyback Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Abbott Laboratories's 3-Month Share Buyback Ratio distribution charts can be found below:

* The bar in red indicates where Abbott Laboratories's 3-Month Share Buyback Ratio falls into.

Save Embed

;

Save Embed

;

Abbott Laboratories 3-Month Share Buyback Ratio Calculation

Abbott Laboratories's 3-Month Share Buyback Ratio for the quarter that ended in Mar. 2025 is calculated as

3-Month Share Buyback Ratio	=	(Shares Outstanding (EOP) (Dec. 2024 )	-	Shares Outstanding (EOP) (Mar. 2025 ))	/	Shares Outstanding (EOP) (Dec. 2024 )
	=	(1731.698	-	1739.837)	/	1731.698
	=	-0.47%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Abbott Laboratories (NYSE:ABT) 3-Month Share Buyback Ratio Explanation

A positive ratio may indicates share buybacks over the period, while a zero or negative ratio suggests no buybacks or potential share issuance.

Be Aware

Investors usually like share buybacks. But as pointed by Warren Buffett, only if a company buys back shares at the prices below the stock's intrinsic value, it rewards remaining shareholders. If a company buys its overvalued stocks back, it destroys shareholder value.

Abbott Laboratories 3-Month Share Buyback Ratio Related Terms

Abbott Laboratories Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Abbott Laboratories (NYSE:ABT) » Definitions » 3-Month Share Buyback Ratio

Comparable Companies

Traded in Other Exchanges

ABT:Mexico 1ABT:Italy 0Q15:UK ABL:Germany ABL:Germany ABL:Germany ABL:Germany ABT:Canada ABTT34:Brazil ABT:Austria ABT:Argentina

Address

100 Abbott Park Road, Abbott Park, IL, USA, 60064-6400

Website

https://www.abbottinvestor.com

Abbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, continuous glucose monitors, and immunoassays and point-of-care diagnostic equipment. Abbott derives approximately 60% of sales outside the United States.

Executives

Sally E. Blount	director	100 ABBOTT PARK ROAD, ABBOTT PARK IL 60064-6400
Lisa D Earnhardt	officer: Executive Vice President	1555 ADAMS DRIVE, C/O INTERSECT ENT, INC., MENLO PARK CA 94025
Andrea F Wainer	officer: Executive Vice President	100 ABBOTT PARK ROAD, ABBOTT PARK IL 60064
Mary K Moreland	officer: Executive Vice President	100 ABBOTT PARK ROAD, ABBOTT PARK IL 60064
Louis H. Morrone	officer: EXECUTIVE VICE PRESIDENT	100 ABBOTT PARK ROAD, ABBOTT PARK IL 60064
Mccoy John A. Jr.	officer: VICE PRESIDENT	C/O ABBOTT LABORATORIES, 100 ABBOTT PARK ROAD, ABBOTT PARK IL 60064
Robert B Ford	officer: Senior Vice President	100 ABBOTT PARK ROAD, AP6A-2, D-032L, ABBOTT PARK IL 60064-6092
Salvadori Daniel Gesua Sive	officer: Senior Vice President	100 ABBOTT PARK ROAD, AP6A-2, D-032L, ABBOTT PARK IL 60064-6092
Hubert L Allen	officer: Executive Vice President	100 ABBOTT PARK ROAD, AP6C-1N, ABBOTT PARK IL 60064-6092
Robert E Funck	officer: Vice President, Controller	100 ABBOTT PARK ROAD, D-378, AP6D-2, ABBOTT PARK IL 60064-6092
Daniel J Starks	director	ONE ST JUDE MEDICAL DRIVE, ST PAUL MN 55117
Michael F Roman	director	3M COMPANY OFFICE OF GENERAL COUNSEL, 3M CENTER, ST. PAUL MN 55144-1000
Patricia Paola Gonzalez	director	100 ABBOTT PARK ROAD, ABBOTT PARK IL 60064
Philip P Boudreau	officer: Vice President	100 ABBOTT PARK ROAD, ABBOTT PARK IL 60064
Michael O'grady	director	50 S LASALLE STREET, CHICAGO IL 60603